Skye Chilton News Today

Mushroom extract supplier Nammex has expanded its cultivation of turkey tail mushrooms in response to an exponential growth in demand.

Mushroom extract supplier Nammex has expanded its cultivation of turkey tail mushrooms in response to an exponential growth in demand.

The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.

The mini-economies generated by these different mushroom sectors are nothing short of staggering.

A Nammex-commissioned survey of 10,000 people in the US confirms the population can easily identify a mushroom. The task may seem simple, but the act supports a greater argument by Nammex, the supplier of functional mushroom extracts, that mycelium-containing products are not mushrooms.

Defining mushroom products reflects a larger problem in the supplements industry: there is precious little oversight and no need for FDA approval.

Heightened awareness during the pandemic may have boosted year-round interest in supplementing healthy lifestyles holistically, but retail data shows that consumers have reverted to pre-pandemic habits of priming their immune systems during the cold and flu season.

Fungi Perfecti, a supplier of mycelium-based supplements, has written an open letter to address the citizen petition filed by mushroom extract company Nammex, which requested that the Food and Drug Administration act to ensure proper labeling of fungi and fungal ingredients.

/PRNewswire/ -- Health11News Corp. announced today that it has awarded its Consumer Quality Health Award, for the best product value and the most impressive...

REAL MUSHROOMS, an industry-leading supplier of premium mushroom supplements, is rated as one of the markets best brands by discerning consumers of functional...